Arrowhead Pharmaceuticals Inc (ARWR)

Exchange
NASDAQ
Symbol
ARWR
Sector
Trade & Services
Industry
Services-commercial Physical & Biological Research
Description
Arrowhead Pharmaceuticals, Inc. develops drugs for the treatment of intractable diseases in the United States. The company is headquartered in Pasadena, California.
Country
USA

Stock price

At close: December 20, 2024

  • Open
    19.38
  • High
    20.21
  • Low
    19.18
  • Close
    19.45
  • Volume
    4,011,130

Financial ratios

Sep 30, 2024

Activity ratios
Inventory turnover
—
Receivables turnover
—
Payables turnover
9.56
Working capital turnover
0.01
Days of inventory on hand (DOH)
—
Days of sales outstanding (DSO)
—
Number of days of payables
38.19
Fixed asset turnover
0.01
Total asset turnover
0.00
 Liquidity ratios
Current ratio
6.74
Quick ratio
6.57
Cash ratio
6.57
Cash conversion cycle
-38.19
 Solvency ratios
Debt-to-assets ratio
0.34
Debt-to-capital ratio
0.68
Debt-to-equity ratio
2.12
Financial leverage ratio
6.15
Interest coverage
-18.15
 Profitability ratios
Gross profit margin
-3,322.70%
Operating profit margin
-16,927.06%
Pretax margin
-16,960.29%
Net profit margin
-16,882.37%
Operating return on assets (Operating ROA)
-52.74%
Return on assets (ROA)
-52.60%
Return on total capital
-101.48%
Return on equity (ROE)
-323.27%